https://doctransparency.com/doctor/fl/margate/jigar-shah-1659508166
Medicare Enrolled

Dr. Jigar Shah, M.D.

Hospitalist Physician · Margate, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
5901 COLONIAL DR STE 303, Margate, FL 33063
9542818891
In practice since 2009 (16 years)
NPI: 1659508166 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shah

Dr. Jigar Shah is a hospitalist physician in Margate, FL, with 16 years in practice. Based on federal Medicare data, Dr. Shah performed 88,903 Medicare services across 1,016 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shah received a total of $563,100 from 53 pharmaceutical and/or device companies across 1211 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hospitalist physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ Top 0% volume in FL$ $563,100 industry payments

Medicare Practice Summary

Medicare Utilization ↗
88,903
Medicare services
Top 0% in FL for hospitalist physician
1,016
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,556 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)36,800$4$13
Tocilizumab injection (Actemra)23,873$4$7
Romosozumab injection (Evenity) for osteoporosis19,320$8$26
Denosumab injection (Prolia/Xgeva)6,420$17$33
Office visit, established patient (30-39 min)491$100$270
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle420$59$187
Dexamethasone injection (steroid)310$0$15
Office visit, established patient (20-29 min)245$70$184
Administration of chemotherapy into vein, 1 hour or less231$107$345
Administration of chemotherapy into vein, each additional hour167$23$110
Infusion, normal saline solution, 250 cc103$1$1
New patient office visit (45-59 min)97$125$415
Injection, methylprednisolone acetate, 40 mg82$6$30
Injection of additional new drug or substance into vein71$13$85
Injection, methylprednisolone sodium succinate, up to 125 mg69$4$60
Aspiration and/or injection of fluid large joint using ultrasound guidance64$81$233
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less60$23$67
Joint injection, major joint36$53$175
Office visit, established patient, complex (40-54 min)27$142$364
New patient office visit (30-44 min)17$78$273
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
98.8% medium
1.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$563,100
Total received (2018-2024)
Avg $80,443/year across 7 years
Top 0% in FL for hospitalist physician
53
Companies
1,211
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$547,681 (97.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,364 (1.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,682 (1.0%)
Scientific / Research
Research funding and grants
$373 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$165,952
2023
$116,591
2022
$128,058
2021
$60,386
2020
$21,732
2019
$42,179
2018
$28,202

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Horizon Therapeutics plc
$203,976
GlaxoSmithKline, LLC.
$131,562
Amgen Inc.
$101,768
AstraZeneca Pharmaceuticals LP
$82,172
Horizon Pharma plc
$22,769
Aurinia Pharma U.S., Inc.
$5,055
OraPharma, a division of Bausch Health US, LLC
$4,174
Janssen Biotech, Inc.
$1,714
AbbVie, Inc.
$1,408
UCB, Inc.
$1,051
Biogen, Inc.
$1,019
ABBVIE INC.
$698
Mallinckrodt Hospital Products Inc.
$668
Radius Health, Inc.
$625
AbbVie Inc.
$552
PFIZER INC.
$514
Novartis Pharmaceuticals Corporation
$503
Lilly USA, LLC
$437
Genentech USA, Inc.
$256
Actelion Pharmaceuticals US, Inc.
$171
E.R. Squibb & Sons, L.L.C.
$167
ANI Pharmaceuticals, Inc.
$147
GENZYME CORPORATION
$138
Mallinckrodt LLC
$134
Organon LLC
$123
SOBI, INC
$102
Mallinckrodt Enterprises LLC
$91
Kiniksa Pharmaceuticals, Ltd.
$80
Boehringer Ingelheim Pharmaceuticals, Inc.
$77
Fresenius Kabi USA, LLC
$72
Celgene Corporation
$66
Novo Nordisk Inc
$65
Kiniksa Pharmaceuticals International, plc
$61
Merck Sharp & Dohme Corporation
$60
Acclarent, Inc
$57
MML US, Inc.
$50
Mylan Institutional Inc.
$48
Flexion Therapeutics, Inc.
$46
DePuy Synthes Sales Inc.
$46
SCILEX PHARMACEUTICALS INC.
$39
Sandoz Inc.
$37
Teva Pharmaceuticals USA, Inc.
$36
SANOFI-AVENTIS U.S. LLC
$34
MEDEXUS PHARMA, INC.
$31
Bioventus LLC
$30
Alvogen Inc
$27
Organon Llc
$25
Biocon Biologics Inc
$25
Exeltis, USA Inc.
$24
Octapharma USA, Inc.
$20
Ultragenyx Pharmaceutical Inc.
$19
FIDIA PHARMA USA INC.
$16
TerSera Therapeutics LLC
$14
Top 3 companies account for 77.7% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DUEXIS · Durolane · EVENITY · Enbrel · FORTEO · HADLIMA · HUMIRA · HYRIMOZ · Hulio · Humira · IDACIO · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · NEUTRASAL · NuDyn · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · ORTHOVISC · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · QMIIZ ODT · RAYOS · RELIEVA SPINPLUS Balloon Sinuplasty System · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · ReActiv8 · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · SYNVISC-ONE · TALTZ · TAVNEOS · TEPEZZA · TERIPARATIDE · TREMFYA · Tavneos · Truxima · Tymlos · UPLIZNA · VIMOVO · XELJANZ · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hospitalist physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for hospitalist physician in FL.

Equivalent to $633 per 100 Medicare services performed
Looking for a hospitalist physician in Margate?
Compare hospitalist physicians in the Margate area by procedure volume, costs, and industry payment transparency.
Browse hospitalist physicians nearby

Geographic Context

Hospitalist Physicians within 10 mi
97
Per 100K population
5.0
County median income
$74,534
Nearest hospital
HCA FLORIDA NORTHWEST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Shah is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), and high industry engagement (speaking/promotional, top 0%), with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Shah experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Shah performed 36,800 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $563,100 from 53 companies across 1,211 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other hospitalist physicians in Margate?
Dr. Shah's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →